Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vomeronasal type-1 receptor 60 pseudogene (VN1R60P, ENSG00000261048) is classified as a pseudogene in the human genome, meaning it does not produce a functional protein product. VN1R pseudogenes are derived from the vomeronasal receptor family, a group of G protein-coupled receptors (GPCRs) implicated in pheromone detection in many vertebrates. However, in humans, most of these genes—including VN1R60P—have lost function due to accumulated mutations. The submitted name "vomeronasal type-1 receptor 4 pseudogene" appears to be a misidentification; ENSG00000261048 and VN1R60P correctly refer to "vomeronasal type-1 receptor 60 pseudogene". As a pseudogene, VN1R60P is neither a functional receptor nor a recognized therapeutic target. No evidence supports its use as a biomarker, its involvement in disease, or any safety/therapeutic concerns. The family of intact vomeronasal type-1 receptors are part of the olfactory GPCR superfamily, but humans have mostly lost these receptors as functional proteins. Thus, this entry is not considered a bona fide therapeutic target and lacks known function, disease association, or drug interaction in humans. VN1R60P is a pseudogene, not a drug target or functional receptor, and should not be used as a canonical biological or therapeutic entity in humans. The original query contains some confusion regarding its identity and target relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal type-1 receptor 60 pseudogene (VN1R60P).